Palladated and platinated complexes derived from phenylacetaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cells. Formation of DNA interstrand cross-links by these complexes

Journal of Inorganic Biochemistry

Volumn 70, Issue 2, 1998, Pages 117-123

  Quiroga, Adoración G ^a   Pérez, José M ^a   Montero, Eva I ^a   Masaguer, José R ^a   Alonso, Carlos ^a   Navarro Ranninger, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Pt and Pd thiosemicarbazone complexes

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; PALLADIUM; THIOSEMICARBAZIDE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CROSS LINKING; CYTOPATHOGENIC EFFECT; DNA DRUG COMPLEX; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MONOCYTIC LEUKEMIA; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CISPLATIN; CROSS-LINKING REAGENTS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HELA CELLS; HL-60 CELLS; HUMANS; INDICATORS AND REAGENTS; JURKAT CELLS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; PLASMIDS; THIOSEMICARBAZONES; TUMOR CELLS, CULTURED;

EID: 0344447073     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(98)10007-7     Document Type: Article

References (40)

1. Carter S.K. Cancer Chemother. Pharmacology. 1:1978;69.
2. Cleare M.J. Coord. Chem. Rev. 12:1974;479.
3. Roberts J.J., Thomson A.J. Prog. Nuc, Acid Res. and Mol. Biol. 22:1979;71.
4. M.J. Cleare, P.C. Hydes, D.R. Herpburn, B.M. Malerbi, Cisplatin, Current Status and New Developments in: A.W. Pestayko, S.T. Crooke, S.K. Carter (Eds.), Academic Press, London, 1980.
5. P.C Hydes, Platinum Coordination Complexes in Cancer Chemotherapy, in: M.P. Hacker, E.B. Douple, I.H. Krakoff (Eds.), Martinus Nijhoff, Boston, 1984.
6. S.B. Howell (Ed.), Platinum and other Metal Coordination Compounds in Cancer Chemotherapy, Plenum Press, New York and London, 1991.
7. N. Farrell, Transition Metal Complexes as Drugs and Chemoterapeutic Agents, in: R. Ugo, B.R. James (Eds.), Kluwer Academic Publishers, Dordrecht, 1989.
8. Macquet J.P., Butons J.L. J. Nat. Cancer. Inst. 70:1983;899.
9. Reedijk J. Inorg. Chim. Acta. 198:1992;873.
10. Rice J.A., Crothers D.M., Pinto A.L., Lippard S.J. Proc. Natl. Acad. Sci. USA. 85:1988;4158.
11. Ronen D., Sherman L., Bar-Nun S., Teitz Y. Antimicrob. Aagents Chemoth. 31:1987;1798.
12. Hall I.H., Rajendran K.G., West D.X., Liberta A.E. AntiCancer. 4:1993;231.
13. S.B. Padhye, G.B. Kauffman, Coord. Chem. Revs. 63 (1985) 127 and references therein.
14. Kumbhar A.S., Padhye S.B., Saraq A.P., Mahajan H.B., Chopade B.A., West D.X. Biol. Mets. 4:1991;141.
15. D.X. West, S.B. Padhye, P.B. Sonawane, Structure and bonding 29 (1) (1991) and references therein.
16. A. Macias, M.C. Rodriguez-Arguelles, M.Y. Suáres, A. Sánchez, J.S. Casas, J. Sordo, U. Englert, J. Chem. Soc. Dalton Trans. 1787 (1989).
17. Casas J.C., Sánchez A., Sordo J., Vázquez-López A., Castellano E.E., Zukerman-Schpector J., Rodriguez-Arguelles M.C., Ruso U. Inorg. Chim. Acta. 216:1994;169.
18. García-Tojal J., García-Jaca J., Cortés R., Rojo T., Urtiaga M.K., Arriortua M.I. Inorg. Chim. Acta. 249:1996;25.
19. West D.X., Bain G.A., Butcher R.J., Jasinski J.P., Li Y., Pozdniakiv R.Y., Valdés-Martínez J., Toscano R.A., Hernández-Ortega S. Polyhedron. 15:1996;665.
20. A.G. Quiroga, J.M. Pérez, C. Alonso, C. Navarro-Ranninger, Appl. Organomet. Chem. (1998) in press.
21. A.G. Quiroga, J.M. Pérez, I. López-Solera, J.R. Masaguer, A. Luque, P. Román, C. Alonso, C. Navarro-Ranninger, J. Med. Chem. (1998) in press.
22. A.G. Quiroga, J.M. Pérez, J. Lopez-Solera, E.I. Montero, J.R. Masaguer, C. Alonso, C. Navarro-Ranninger, J. Inorg. Biochem. 69 (1998) 275.
23. Sah P.P.T., Daniels T.C. Rec. Trav. Chim. 69:1950;1545.
24. Alley M.C., Scudiero A., Monks M., Huresey M.L., Czerwinski D.L., Fine B.J., Abbott J.G., Shoemaker R.H., Boyd M.R. Cancer Research. 48:1988;589.
25. Hingorani S., Agarwal B.V. Spect. Lett. 23:1990;1097.
26. K Chattopadhyay S., Chattopadhyay D., Banerjee T., Kudora R., Ghosh S. Polyhedron. 16:1997;1925.
27. West D.X., Ives J.S., Krejci J., Salberg M.M., Zumbahlen T.L., Bain G.A., Liberta A.E., Valdés-Martínez J., Hernández-Ortiz S., Toscano R.A. Polyhedron. 14:1995;2189.
28. Valdés-Martínez J., Toscano R.A., Zentella-Dehesa A., Salberg M.M., Bain G.A., West D.X. Polyhedron. 15:1996;427.
29. Berkessel A., Hermann G., Ranch O.T., Bütcher M., Jacobi A., Hutlner G. Chem. Ber. 129:1996;1421.
30. Kovala-Demertzi D., Domopoulo A., Demertzi M.A., Valdés-Martínez J., Hernández-Ortega S., Espinosa-Pérez G., West D.X., Salberg M.M., Bain G.A., Bloom P.D. Polyhedron. 15:1996;2587.
31. C.Y. Duan, B.M. Wu, T.C.W. Mak, J. Chem. Soc. Dalton Trans. 3485 (1996).
32. Maji M., Ghosh S., Chattopadhayay S.K., Mak T.C.W. Inorg. Chem. 36:1997;2938.
33. B. Crociani, R. Boschi, R. Pietropaolo, U. Belluco, J. Chem. Soc. (A) 531 (1970).
34. S.G. Teoh, S.H. Ang, S.B. Teo, H.K. Fun, K.L. Khew, C.W. Ong, J. Chem. Soc. Dalton Trans. 465 (1997).
35. Sherman S.E., Lippard S.J. Chem. Rev. 87:1987;1153.
36. Johnson D.H., Hainsworth J.D., Hande K.R., Greco F.A. Cancer. 67:1991;231.
37. C. Henderson, J.R. Harris, D.W. Kinne, S. Hellman, in: V.T. DeVita, S. Hellman, I.C. Henderson, D.W. KInne (Eds.), Cancer Principles & Practice of Oncology, Philadelphia. J.B. Lippincott. 1987, p. 398.
38. Roberts J.P., VanHouten B.V., Qu Y., Farrell N. Nucleic Acids Res. 17:1989;971939.
39. Navarro-Ranninger C., López-Solera I., Pèrez J.M., Rodriguez J., García-Ruano J.L., Raithby P., Masaguer J.R., Alonso C. J. Med. Chem. 36:1993;3795.
40. N. Farrell, in: R. Ugo, B.R. James (Eds.), Transition Metal Complexes as Drugs and Chemotherapeutic Agents, Kluwer Academic Publishers, London, 1989, p. 144.